Benzinga | Oct 26, 2020 06:55AM EDT

HC Wainwright & Co. Maintains Buy on Revolution Medicines, Raises Price Target to $54

HC Wainwright & Co. maintains Revolution Medicines (NASDAQ:RVMD) with a Buy and raises the price target from $52 to $54.